Drug Type Antisense oligonucleotides, Exosomes |
Synonyms- |
Target |
Mechanism CEBPB modulators(CCAAT enhancer binding protein beta modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bladder Cancer | Preclinical | US | 07 Nov 2022 | |
Breast Cancer | Preclinical | US | 07 Nov 2022 | |
Hepatocellular Carcinoma | Preclinical | US | 07 Nov 2022 | |
Melanoma | Preclinical | US | 07 Nov 2022 |